COVID-19 Updates

Like many organizations across the country and around the world, Lundbeck is closely monitoring the COVID-19 outbreak and its impact on our patients, communities and fiercely dedicated healthcare providers.

Lundbeck's Response to COVID-19 

Our utmost priority is to protect the well-being of the communities we serve and our 1,000 Lundbeck colleagues nationwide, and so we are taking responsible action within our control to limit the rapid escalation of the virus and maintain support of our provider and patient communities.

Information for Healthcare Professionals 

We are proud to continue to partner with healthcare professionals to serve those living with brain diseases during this unprecedented time. 

Patient Assistance

Lundbeck is committed to developing and providing innovative therapies that help improve patients' lives. As part of our commitment, we work to provide appropriate assistance to patients who seek access to our therapies. The Lundbeck Patient Assistance Program (PAP) may be available to patients who have limited financial resources and who do not have insurance coverage for their medication. Eligibility criteria apply.

A Message from Our President & CEO 

In this video, Lundbeck’s President and CEO, Dr. Deborah Dunsire, thanks the dedicated frontline healthcare workers who are battling the coronavirus. She also expresses gratitude for providers who manage the healthcare needs of people living with psychiatric and neurological disorders, and she shares how Lundbeck is providing support to people living with brain diseases during this unprecedented time of history.

Looking Out for the Invisibly Vulnerable in the Time of COVID-19 

We know that seniors and people with underlying health conditions are more likely to experience serious complications if they contract the virus. But there is another community that also is at risk and needs our attention: People living with brain diseases are especially vulnerable to the effects of stress, and stress levels are now dramatically on the rise. For people who live with existing mental health conditions such as depression, bipolar disorder or schizophrenia, or neurological conditions such as migraine, increased stress could lead to a relapse or serious worsening of symptoms.

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck.